Sintx Technologies (NASDAQ:SINT – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Sintx Technologies to similar companies based on the strength of its dividends, risk, analyst recommendations, earnings, profitability, valuation and institutional ownership.
Dividends
Sintx Technologies pays an annual dividend of $0.60 per share and has a dividend yield of 46.3%. Sintx Technologies pays out -35.5% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 47.3% of their earnings in the form of a dividend. Sintx Technologies is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Sintx Technologies and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
| Sintx Technologies Competitors | 4311 | 10598 | 18391 | 838 | 2.46 |
Sintx Technologies currently has a consensus target price of $9.50, indicating a potential upside of 633.02%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.38%. Given Sintx Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than its competitors.
Profitability
This table compares Sintx Technologies and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -281.91% | -309.86% | -101.90% |
| Sintx Technologies Competitors | -270.28% | -155.47% | -22.38% |
Institutional and Insider Ownership
18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 8.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Sintx Technologies and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Sintx Technologies | $3.02 million | -$10.36 million | -0.77 |
| Sintx Technologies Competitors | $1.89 billion | $135.83 million | 5.76 |
Sintx Technologies’ competitors have higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Summary
Sintx Technologies competitors beat Sintx Technologies on 9 of the 14 factors compared.
About Sintx Technologies
SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications. In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
